{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:49:36Z","timestamp":1792147776725,"version":"4.4.0"},"reference-count":16,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A wide variety of endocrine disorders caused by sarcoidosis have been reported to date. We report the case of an 82-year-old male patient who presented with hypercalcemia and anterior pituitary hormone deficiency at the time of his sarcoidosis diagnosis and was subsequently diagnosed with arginine vasopressin deficiency (AVP-D) 6 months after the initiation of glucocorticoid therapy. Magnetic resonance imaging revealed an enlarged pituitary gland, thickened pituitary stalk, and loss of the posterior pituitary bright spot, raising the suspicion of hypothalamic\u2013pituitary sarcoidosis. Despite improvement in hypercalcemia, anterior pituitary function, and pituitary enlargement and stalk thickening with glucocorticoid therapy, subjective symptoms of dry mouth and polyuria gradually became apparent several months after the start of treatment. While the characteristic hypotonic polyuria of AVP-D was not prominent, we surmised that these typical clinical features were masked by adrenal insufficiency, chronic kidney disease (CKD), and concurrent use of a sodium\u2013glucose cotransporter 2 (SGLT2) inhibitor for type 2 diabetes. This case highlights the fact that the typical presentation of AVP-D can be masked by concurrent SGLT2 inhibitor use and CKD, emphasizing careful assessment of water balance in such patients.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag318","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:49:24Z","timestamp":1790855364000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic challenges of masked arginine vasopressin deficiency in neurosarcoidosis complicated by sodium\u2013glucose cotransporter 2 inhibitor use"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5341-507X","authenticated-orcid":false,"given":"Ryohei","family":"Nonaka","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Oita Prefectural Hospital , Oita City, Oita 870-0855 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Oita Prefectural Hospital , Oita City, Oita 870-0855 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Tomimoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Oita Prefectural Hospital , Oita City, Oita 870-0855 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Oita Prefectural Hospital , Oita City, Oita 870-0855 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Oita Prefectural Hospital , Oita City, Oita 870-0855 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6506-4820","authenticated-orcid":false,"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University , Yufu City, Oita 879-5593 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"2","key":"2026101606195981000_luag318-B1","article-title":"Panhypopituitarism in neurosarcoidosis: pituitary-hypothalamic involvement successfully managed with rituximab","volume":"3","author":"De Miguel Iba\u00f1ez","year":"2025","journal-title":"JCEM Case Rep"},{"issue":"10","key":"2026101606195981000_luag318-B2","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-235077","article-title":"Neurosarcoidosis presenting with hypopituitarism","volume":"13","author":"Liu","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2026101606195981000_luag318-B3","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-216696","article-title":"Systemic sarcoidosis with hypercalcemia, hypothalamic-pituitary dysfunction and thyroid involvement","volume":"2016","author":"Alsahwi","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"1","key":"2026101606195981000_luag318-B4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.33590\/emjneurol\/10310819","article-title":"Hypothalamic-pituitary alterations in patients with neurosarcoidosis","volume":"3","author":"Martin-Grace","year":"2015","journal-title":"EMJ Neurol"},{"issue":"10","key":"2026101606195981000_luag318-B5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","article-title":"Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients","volume":"105","author":"Langrand","year":"2012","journal-title":"QJM"},{"issue":"10","key":"2026101606195981000_luag318-B6","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.71106","article-title":"Hypothalamic neurosarcoidosis with multisystem involvement: case report and literature review","volume":"13","author":"Al-Badri","year":"2025","journal-title":"Clin Case Rep"},{"key":"2026101606195981000_luag318-B7","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206390","article-title":"Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency","volume":"2015","author":"Non","year":"2015","journal-title":"BMJ Case Rep"},{"key":"2026101606195981000_luag318-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/145856","article-title":"Arginine vasopressin-independent mechanism of impaired water excretion in a patient with sarcoidosis complicated by central diabetes insipidus and glucocorticoid deficiency","volume":"2011","author":"Yoshioka","year":"2011","journal-title":"Case Rep Med"},{"issue":"1","key":"2026101606195981000_luag318-B9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13256-021-03229-y","article-title":"Masked diabetes insipidus in pituitary metastasis from breast cancer after thalamic biopsy: a case report","volume":"16","author":"Hashimoto","year":"2022","journal-title":"J Med Case Rep"},{"issue":"1","key":"2026101606195981000_luag318-B10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12902-025-01924-1","article-title":"SGLT2 inhibitor in a type 2 diabetes mellitus patient coexisted with central diabetes insipidus following hyperosmolar hyperglycemic state","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"2026101606195981000_luag318-B11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.47102\/annals-acadmedsg.2020418","article-title":"Adipsic diabetes insipidus and SGLT2 inhibitor: a perplexing conundrum","volume":"50","author":"Chua","year":"2021","journal-title":"Annals Acad Med Singap"},{"key":"2026101606195981000_luag318-B12","article-title":"Dysnatremias in chronic kidney disease: pathophysiology, manifestations, and treatment","volume":"8","author":"Arzhan","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"2026101606195981000_luag318-B13","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s11255-023-03813-9","article-title":"Alteration of the maximal renal water excretion capacity with kidney function and age in human","volume":"56","author":"Zettl","year":"2024","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2026101606195981000_luag318-B14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ckj\/sfs170","article-title":"Pre-existing undiagnosed central diabetes insipidus unmasked after renal transplantation","volume":"6","author":"Munoz-Mendoza","year":"2013","journal-title":"Clin Kidney J"},{"key":"2026101606195981000_luag318-B15","article-title":"Hypothalamic-pituitary axis dysfunction, central diabetes insipidus, and syndrome of inappropriate antidiuretic hormone secretion as the first clinical presentation of neurosarcoidosis: why early diagnosis and treatment is important?","volume":"12","author":"Blazin","year":"2020","journal-title":"Cureus"},{"issue":"16","key":"2026101606195981000_luag318-B16","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.2169\/internalmedicine.51.6957","article-title":"Partial improvement of anterior pituitary deficiency following steroid treatment in a patient with neurosarcoidosis accompanied by central diabetes insipidus","volume":"51","author":"Tanaka","year":"2012","journal-title":"Intern Med"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/12\/luag318\/72037009\/luag318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/12\/luag318\/72037009\/luag318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:20:04Z","timestamp":1792146004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag318\/8931457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,10,16]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag318","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,12]]},"published":{"date-parts":[[2026,10,16]]},"article-number":"luag318"}}